Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

To help health policy makers gain response time to mitigate infectious disease threats, it is essential to have an efficient epidemic surveillance. One common method of disease surveillance is to carefully select nodes (sentinels, or sensors) in the network to report outbreaks. One would like to choose sentinels so that they discover the outbreak as early as possible. The optimal choice of sentinels depends on the network structure. Studies have addressed this problem for static networks, but this is a first step study to explore designing surveillance systems for early detection on temporal networks. This paper is based on the idea that vaccination strategies can serve as a method to identify sentinels. The vaccination problem is a related question that is much more  well studied for temporal networks. To assess the ability to detect epidemic outbreaks early, we calculate the time difference (lead time) between the surveillance set and whole population in reaching 1% prevalence. We find that the optimal selection of sentinels depends on both the network's temporal structures and the infection probability of the disease. We find that, for a mild infectious disease (low infection probability) on a temporal network in relation to potential disease spreading (the Prostitution network), the strategy of selecting latest contacts of random individuals provide the most amount of lead time. And for a more uniform, synthetic network with community structure the strategy of selecting frequent contacts of random individuals provide the most amount of lead time.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500503PMC
http://dx.doi.org/10.1038/s41598-017-03868-6DOI Listing

Publication Analysis

Top Keywords

lead time
12
temporal network
8
infectious disease
8
sentinels depends
8
temporal networks
8
infection probability
8
strategy selecting
8
contacts random
8
random individuals
8
individuals provide
8

Similar Publications

Purpose: Early detection of HPV-associated oropharyngeal cancer (HPV+OPSCC), the most common HPV cancer in the United States, could reduce disease-related morbidity and mortality, yet currently, there are no early detection tests. Circulating tumor HPV DNA (ctHPVDNA) is a sensitive and specific biomarker for HPV+OPSCC at diagnosis. It is unknown if ctHPVDNA is detectable prior to diagnosis, and thus it's potential as an early detection test.

View Article and Find Full Text PDF

Background: Electronic health records (EHRs) have been linked to information overload, which can lead to cognitive fatigue, a precursor to burnout. This can cause health care providers to miss critical information and make clinical errors, leading to delays in care delivery. This challenge is particularly pronounced in medical intensive care units (ICUs), where patients are critically ill and their EHRs contain extensive and complex data.

View Article and Find Full Text PDF

Congenital syphilis is a preventable yet severe condition resulting from untreated maternal syphilis. Since 2016, Australia has recorded over 95 congenital syphilis cases, with 31/95 (33%) associated with perinatal death. Syphilis serology is complex and therefore performed in designated central laboratories.

View Article and Find Full Text PDF

The correlation between Pb species formation and bioaccessibility in alkaline, smelter-impacted soil co-contaminated with other toxic trace elements after treatment with phosphorus-containing amendments was investigated. The soil was collected near a former copper smelter, El Paso, Texas. It contained Pb (3200 ± 142 mg kg), As (254 ± 14 mg kg), and Cd (110 ± 8 mg kg).

View Article and Find Full Text PDF

Background: Current aftercare in breast cancer survivors aims to detect local recurrences or contralateral disease, while the detection of distant metastases has not been a central focus due to a lack of evidence supporting an effect on overall survival. However, the data underpinning these guidelines are mainly from trials of the 1980s/1990s and have not been updated to reflect the significant advancements in diagnostic and therapeutic options that have emerged over the past 40 years. In this trial, the aim is to test whether a liquid biopsy-based detection of (oligo-) metastatic disease at an early pre-symptomatic stage followed by timely treatment can impact overall survival compared to current standard aftercare.

View Article and Find Full Text PDF